Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.AlphaVax names new vice president of clinical operations
In this capacity Ms Baird will provide leadership and strategic direction in the areas of regulatory and quality affairs and in clinical operations. Most recently, Ms Baird was
In this capacity Ms Baird will provide leadership and strategic direction in the areas of regulatory and quality affairs and in clinical operations. Most recently, Ms Baird was
“In his eight years at Novo Nordisk, Andy has developed an impressive track record for building high performing field sales teams,” said Jerzy Gruhn, president of Novo Nordisk
CE marking means conformity to the applicable European directive and in the specific context of diabetes, permits the Cypher Select Plus stent to be marketed for the treatment
The agreements concern both the distribution rights for MultiSynTech’s systems and the establishment of a joint development project. The agreements with MultiSynTech will grant Biotage distribution rights for
“Gen-Probe posted strong financial results in the fourth quarter of 2008, driven by healthy growth in both clinical diagnostics and blood screening sales,” said Hank Nordhoff, the company’s
The trial currently conducted in the UK is investigating the safety and efficacy of Sanofi Pasteur’s Clostridium difficile (CDI) candidate vaccine. While the target indication for the vaccine
The current Phase I trial is the first time CB-183,315 has been given to humans and is designed to evaluate the safety and pharmacokinetics of single escalating oral
Dr Nichols previously served as regional chairman, medical director, and director of hematopathology of the Bon Secours Richmond Regional Laboratory System, and is a past president of the
Under the companies’ collaboration agreement, Curis will receive a $6 million cash payment from Genentech following initiation of this pivotal trial. Genentech expects to evaluate GDC-0449 in approximately
The BioMask is said to be the first in a series of new products in Filligent’s anti-microbial personal care range, BioFriend, to be launched during 2009. By complying